Use of non-conventional medicine two years after cancer diagnosis in France: evidence from the VICAN survey.

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA (1998) 35.46

Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med (1993) 28.86

Why patients use alternative medicine: results of a national study. JAMA (1998) 17.91

Use of alternative medicine by women with early-stage breast cancer. N Engl J Med (1999) 7.37

Chronic illness as biographical disruption. Sociol Health Illn (1982) 6.42

Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol (2000) 5.48

Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst (2002) 5.19

Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain (2005) 4.59

Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med (2001) 4.37

Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol (2005) 3.98

Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol (2000) 3.10

Prevalence of use of complementary/alternative medicine: a systematic review. Bull World Health Organ (2000) 2.92

Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol (2005) 2.87

Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst (2000) 2.87

Why do patients turn to complementary medicine? An empirical study. Br J Clin Psychol (1996) 2.54

How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integr Cancer Ther (2011) 2.43

French national health insurance information system and the permanent beneficiaries sample. Rev Epidemiol Sante Publique (2010) 2.08

Relationship between preferences for decisional control and illness information among women with breast cancer: a quantitative and qualitative analysis. Soc Sci Med (1994) 2.06

Cancer patients use of nonproven therapy: a 5-year follow-up study. J Clin Oncol (1998) 2.05

Health care and consumer choice: medical and alternative therapies. Soc Sci Med (1997) 1.77

Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J Clin Epidemiol (1997) 1.72

Development and testing of a neuropathic pain screening questionnaire: ID Pain. Curr Med Res Opin (2006) 1.65

A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg (2000) 1.62

An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol (2004) 1.52

The SF-12 as a population health measure: an exploratory examination of potential for application. Health Serv Res (2000) 1.39

Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer (2000) 1.36

The use of complementary therapies by breast cancer patients attending conventional treatment. Eur J Cancer (1998) 1.27

Bridging the gap: decision-making processes of women with breast cancer using complementary and alternative medicine (CAM). Support Care Cancer (2007) 1.20

Decision making related to complementary therapies: a process of regaining control. Patient Educ Couns (1999) 1.17

Complementary alternative treatments used by patients with cancer in eastern Turkey. Cancer Nurs (2003) 1.10

Abandoning biomedicine for alternate therapies: oncology patients' stories. Cancer Nurs (1998) 1.10

Complementary and alternative medicine use among women with breast cancer. Med Anthropol Q (1999) 1.07

Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study. AIDS (2007) 1.05

The use of complementary/alternative medicine by cancer patients in a New Zealand regional cancer treatment centre. N Z Med J (2003) 1.04

The choice of alternative therapy for health care: testing some propositions. Soc Sci Med (1996) 1.04

Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer. Eur J Cancer (2009) 1.04

Complementary therapies and integrative medicine in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 1.03

Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer. Urology (2005) 0.95

Perceived cancer causes: use of complementary and alternative therapy. Cancer Pract (2002) 0.93

Effects of age on coping and psychological distress in women diagnosed with breast cancer: review of literature and analysis of two different geographical settings. Crit Rev Oncol Hematol (2003) 0.91

Do attitudes and beliefs regarding complementary and alternative medicine impact its use among patients with cancer? A cross-sectional survey. Cancer (2015) 0.90

Unsafe sex with casual partners and quality of life among HIV-infected gay men: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA). J Acquir Immune Defic Syndr (2006) 0.89

Predictive characteristics of users of alternative medicine. Schweiz Med Wochenschr (2000) 0.89

Perceived quality of life and coping for Swedish women with breast cancer who choose complementary medicine. Cancer Nurs (2001) 0.89

[Use of complementary medicine by cancer patients in a French oncology department]. Bull Cancer (2007) 0.89

The role of complementary and alternative medicine in the management of early breast cancer: recommendations of the European Society of Mastology (EUSOMA). Eur J Cancer (2006) 0.87

Why do some cancer patients receiving chemotherapy choose to take complementary and alternative medicines and what are the risks? Asia Pac J Clin Oncol (2013) 0.85

The labour market, psychosocial outcomes and health conditions in cancer survivors: protocol for a nationwide longitudinal survey 2 and 5 years after cancer diagnosis (the VICAN survey). BMJ Open (2015) 0.84

Initiation and discontinuation of complementary therapy among cancer patients. J Clin Oncol (2007) 0.82

Why patients seek unproven cancer remedies: a psychological perspective. CA Cancer J Clin (1982) 0.82

Prevalence of complementary and alternative therapy use by cancer patients undergoing radiation therapy. Asia Pac J Clin Oncol (2014) 0.81

Complementary and alternative medicine use and disclosure amongst Australian radiotherapy patients. Support Care Cancer (2014) 0.80

Does perceived control predict Complementary and Alternative Medicine (CAM) use among patients with lung cancer? A cross-sectional survey. Support Care Cancer (2014) 0.79

[Use of antioxidant and other complementary medicine by patients treated by antitumor chemotherapy: a prospective study]. Bull Cancer (2011) 0.78

Complementary or alternative medicine as possible determinant of decreased persistence to aromatase inhibitor therapy among older women with non-metastatic breast cancer. PLoS One (2013) 0.77

[Complementary and alternative medicines taken by cancer patients]. Bull Cancer (2007) 0.77

Unproven (unorthodox) cancer treatments: a guide for healthcare professionals. Cancer Pract (1994) 0.76

Does cancer survivors' health-related quality of life depend on cancer type? Findings from a large French national sample 2 years after cancer diagnosis. Eur J Cancer Care (Engl) (2011) 0.76

Unorthodox cancer medicine. Cancer Invest (1986) 0.76